# Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress

> **NCT02904109** · PHASE2 · COMPLETED · sponsor: **Prof. Dominique de Quervain, MD** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Triflusal
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02904109
- **Lead sponsor:** Prof. Dominique de Quervain, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-13
- **Primary completion:** 2017-02-21
- **Final completion:** 2017-02-28
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904109, "Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02904109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*